Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng-Ta Yang

Showing results (271-280 of 310) with videos related to

Pageof 31
Sort By:
Therapeutic Advances in Medical Oncology|July 28, 2022
Comparison of afatinib and erlotinib combined with bevacizumab in untreated stage IIIB/IV epidermal growth factor receptor-mutated lung adenocarcinoma patients: a multicenter clinical analysis studySuey-Haur Lee, Yu-Ching Lin, Li-Chung Chiu, et al.
Frontiers in Immunology|November 7, 2022
Association of smoking status with non-small cell lung cancer patients harboring uncommon epidermal growth factor receptor mutationHow-Wen Ko, Shian-Sen Shie, Chih-Wei Wang, et al.
Vaccines|May 25, 2024
A Clinical Analysis of Anti-Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint Inhibitor Treatments Combined with Chemotherapy in Untreated Extensive-Stage Small-Cell Lung CancerPing-Chih Hsu, Bing-Chen Wu, Chin-Chou Wang, et al.
International Journal of Molecular Sciences|September 23, 2022
Circulating <i>EGFR</i> Mutations in Patients with Lung Adenocarcinoma by Circulating Tumor Cell Isolation Systems: A Concordance StudyShih-Hong Li, Min-Hsien Wu, Hung-Ming Wang, et al.
Frontiers in Immunology|February 28, 2018
Unique Immune Gene Expression Patterns in Bronchoalveolar Lavage and Tumor Adjacent Non-Neoplastic Lung Tissue in Non-Small Cell Lung CancerChih-Hsi Scott Kuo, Chien-Ying Liu, Stelios Pavlidis, et al.
The Annals of Thoracic Surgery|December 3, 2014
Survival predictors in acute respiratory distress syndrome with extracorporeal membrane oxygenationLi-Chung Chiu, Feng-Chun Tsai, Han-Chung Hu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|August 22, 2024
Consensus of the Taiwanese dermatological association and Taiwan Lung Cancer Society on the prevention and management of tyrosine kinase inhibitor-related skin toxicities in patients with non-small cell lung cancer: An updated version incorporating Taiwanese treatment experienceChun-Wei Lu, Chun-Bing Chen, Tsu-Man Chiu, et al.
Cancer Medicine|August 29, 2023
First-line nivolumab, paclitaxel, carboplatin, and bevacizumab for advanced non-squamous non-small cell lung cancer: Updated survival analysis of the ONO-4538-52/TASUKI-52 randomized controlled trialHye Ryun Kim, Shunichi Sugawara, Jong-Seok Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2023
Sybil: A Validated Deep Learning Model to Predict Future Lung Cancer Risk From a Single Low-Dose Chest Computed TomographyPeter G Mikhael, Jeremy Wohlwend, Adam Yala, et al.
Critical Care (London, England)|May 19, 2015
Diffuse alveolar damage associated mortality in selected acute respiratory distress syndrome patients with open lung biopsyKuo-Chin Kao, Han-Chung Hu, Chih-Hao Chang, et al.
Pageof 31

Showing results (271-280 of 310) with videos related to

Sort By:
Pageof 31
Therapeutic Advances in Medical Oncology|July 28, 2022
Comparison of afatinib and erlotinib combined with bevacizumab in untreated stage IIIB/IV epidermal growth factor receptor-mutated lung adenocarcinoma patients: a multicenter clinical analysis studySuey-Haur Lee, Yu-Ching Lin, Li-Chung Chiu, et al.
Frontiers in Immunology|November 7, 2022
Association of smoking status with non-small cell lung cancer patients harboring uncommon epidermal growth factor receptor mutationHow-Wen Ko, Shian-Sen Shie, Chih-Wei Wang, et al.
Vaccines|May 25, 2024
A Clinical Analysis of Anti-Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint Inhibitor Treatments Combined with Chemotherapy in Untreated Extensive-Stage Small-Cell Lung CancerPing-Chih Hsu, Bing-Chen Wu, Chin-Chou Wang, et al.
International Journal of Molecular Sciences|September 23, 2022
Circulating <i>EGFR</i> Mutations in Patients with Lung Adenocarcinoma by Circulating Tumor Cell Isolation Systems: A Concordance StudyShih-Hong Li, Min-Hsien Wu, Hung-Ming Wang, et al.
Frontiers in Immunology|February 28, 2018
Unique Immune Gene Expression Patterns in Bronchoalveolar Lavage and Tumor Adjacent Non-Neoplastic Lung Tissue in Non-Small Cell Lung CancerChih-Hsi Scott Kuo, Chien-Ying Liu, Stelios Pavlidis, et al.
The Annals of Thoracic Surgery|December 3, 2014
Survival predictors in acute respiratory distress syndrome with extracorporeal membrane oxygenationLi-Chung Chiu, Feng-Chun Tsai, Han-Chung Hu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|August 22, 2024
Consensus of the Taiwanese dermatological association and Taiwan Lung Cancer Society on the prevention and management of tyrosine kinase inhibitor-related skin toxicities in patients with non-small cell lung cancer: An updated version incorporating Taiwanese treatment experienceChun-Wei Lu, Chun-Bing Chen, Tsu-Man Chiu, et al.
Cancer Medicine|August 29, 2023
First-line nivolumab, paclitaxel, carboplatin, and bevacizumab for advanced non-squamous non-small cell lung cancer: Updated survival analysis of the ONO-4538-52/TASUKI-52 randomized controlled trialHye Ryun Kim, Shunichi Sugawara, Jong-Seok Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2023
Sybil: A Validated Deep Learning Model to Predict Future Lung Cancer Risk From a Single Low-Dose Chest Computed TomographyPeter G Mikhael, Jeremy Wohlwend, Adam Yala, et al.
Critical Care (London, England)|May 19, 2015
Diffuse alveolar damage associated mortality in selected acute respiratory distress syndrome patients with open lung biopsyKuo-Chin Kao, Han-Chung Hu, Chih-Hao Chang, et al.
Pageof 31